Drawing for IMMUNOMICS

USPTO serial 76244422

IMMUNOMICS

Reviewed by CopyMark Law Group

Status 603
Filing date
Status date
Registration date
—
Examiner
MICHOS, JOHN E
Law office
TMEG LAW OFFICE 105 - EXAMINING ATTORNEY ASSIGNED

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with IMMUNOMICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Horst M. Kasper

HORST M KASPER13 FOREST DRWARREN, NJ 07059UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Medical diagnostic preparations, namely, preparations for the analysis, quantitative and qualitative determination of immunologic sensibilization/s, medical diagnostic preparations for (enzyme) immunoassays, for ELISA (procedures for the determination of immunogens); cell culture; test kit consisting essentially of combinations of the foregoingACTIVE—
010Medical diagnostic apparatus and instruments, namely, medical apparatus and instruments for the determination of immune diseases, determination for (third parties) of genetic and non-genetic states and immunoparaments; determination of the decrease of activity of suppressive T cells, determination of decrease of activity of specific suppressive T cells, determination of increase of the activity of specific T helper cellsACTIVE—
042Medical care and scientific and industrial research in the fields of immune diseases, autoimmune disease (namely autoreactivity directed against host proteins and antigens), auto sensibilization, autoinimunity, autoimmunopathies, autoaggression, HLA system, autoantigens, autoantibodies, autoreative/autoimmune cells, cytokines, antibodies, B cells, T cells, antigen presenting cells, antigen-antybody reaction of antoantigen and specific antoantybody, association of host proteins with haptens rheumatoid arthritis, immunoparmenters of rheumatoid arthritisACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Mar 15, 2013MAB3ABANDONMENT NOTICE MAILED - AFTER EX PARTE APPEAL—
Mar 15, 2013ZZZYPREVIOUS ACTION COUNT WITHDRAWN—
Aug 11, 2004ABN3ABANDONMENT - AFTER EX PARTE APPEAL—
Aug 11, 2004EXPTEXPARTE APPEAL TERMINATED—
Aug 6, 2004MAILPAPER RECEIVED—
Aug 6, 2004EXPIEX PARTE APPEAL-INSTITUTED—
Aug 6, 2004REINREINSTATED—
Jul 22, 2004EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Jul 7, 2004MAILPAPER RECEIVED—
May 20, 2004CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 20, 2004FAXXFAX RECEIVED—
Apr 5, 2004UNPRUNRESPONSIVE/DUPLICATE PAPER RECEIVED—
Apr 5, 2004MAILPAPER RECEIVED—
Nov 7, 2003CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Sep 4, 2003CFITCASE FILE IN TICRS—
Aug 11, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 11, 2003MAILPAPER RECEIVED—
Aug 1, 2003CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Feb 10, 2003CNSIINQUIRY AS TO SUSPENSION MAILED—
Jul 16, 2002CNSLLETTER OF SUSPENSION MAILED—
Jun 4, 2002GNSLLETTER OF SUSPENSION E-MAILED—
Feb 11, 2002CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 9, 2001CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 25, 2001DOCKASSIGNED TO EXAMINER—
May 21, 2001UNPRUNRESPONSIVE/DUPLICATE PAPER RECEIVED—

Frequently asked questions

Related guidance